Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Vestal Point Capital, LP
Form 13F · Q2 2026

Vestal Point Capital, LP

CIK 1974915申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$42.8亿
申报组合市值
68
持仓数量
11
Quarters on record
Top 50
持仓数量

Vestal Point Capital, LP——持仓

共 68 个持仓中的前 50 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1BMRN Biomarin Pharmaceutical Inc6.0M+68.5%$3.4亿8.1%
2NBIX Neurocrine Biosciences Inc1.9M+50.4%$3.2亿7.4%
3ABVX Abivax Sa2.3M+56.6%$3.1亿7.3%
4UTHR United Therapeutics Corp Del435,000+480.0%$2.4亿5.5%
5ELVN Enliven Therapeutics Inc4.0M+23.1%$2.0亿4.7%
6NRIX Nurix Therapeutics Inc8.1M+23.8%$2.0亿4.6%
7BCAX Bicara Therapeutics Inc5.2M−3.2%$1.6亿3.6%
8TSHA Taysha Gene Therapies Inc19.4M+7.9%$1.3亿3.1%
9ARWR Arrowhead Pharmaceuticals In1.6M−30.8%$1.3亿3.0%
10ABT Abbott Laboratories1.4M—$1.3亿3.0%
11ZBH Zimmer Biomet Holdings Inc1.4M+636.8%$1.2亿2.8%
12IRON Disc Medicine Inc1.6M+121.4%$1.1亿2.6%
13GLUE Monte Rosa Therapeutics Inc4.6M+27.7%$1.1亿2.6%
14PODD Insulet Corp670,000+1224.1%$1.0亿2.4%
15ASND Ascendis Pharma A/S375,000—$1.0亿2.3%
16AZN Astrazeneca Plc450,000+350.0%$8533万2.0%
17SNY Sanofi Sa2.0M+42.9%$8532万2.0%
18RVMD Revolution Medicines Inc450,000−81.1%$8428万2.0%
19BCRX Biocryst Pharmaceuticals Inc8.3M+18.1%$8300万1.9%
20DYN Dyne Therapeutics Inc3.4M−15.6%$7496万1.8%
21NKTR Nektar Therapeutics1.0M+250.9%$6981万1.6%
22GMED Globus Med Inc850,000+39.2%$6716万1.6%
23TARS Tarsus Pharmaceuticals Inc1.1M+425.0%$6609万1.5%
24IMTX Immatics N.V6.2M+0.0%$6255万1.5%
25TRVI Trevi Therapeutics Inc3.1M+43.1%$5782万1.4%
26IMCR Immunocore Hldgs Plc1.8M−34.9%$5715万1.3%
27RGEN Repligen Corp400,000−56.8%$5458万1.3%
28BMY Bristol-Myers Squibb Co800,000−20.0%$4610万1.1%
29QURE Uniqure Nv935,000+160.4%$4307万1.0%
30XENE Xenon Pharmaceuticals Inc700,000+9.4%$4225万1.0%
31DRUG Bright Minds Biosciences Inc545,000+10.7%$3826万0.9%
32MDGL Madrigal Pharmaceuticals Inc65,000+106.6%$3490万0.8%
33ALC Alcon Ag500,000−37.5%$3355万0.8%
34MYGN Myriad Genetics Inc5.7M+248.0%$3275万0.8%
35RAPP Rapport Therapeutics Inc730,000−49.2%$3042万0.7%
36CBIO Crescent Biopharma Inc.1.6M+8.7%$2934万0.7%
37GEHC Ge Healthcare Technologies I450,000+80.0%$2880万0.7%
38INSM Insmed Inc250,000—$2666万0.6%
39VKTX Viking Therapeutics Inc680,000−25.6%$2653万0.6%
40BBNX Beta Bionics Inc1.6M−27.7%$2507万0.6%
41REGN Regeneron Pharmaceuticals40,000+0.0%$2494万0.6%
42SLDB Solid Biosciences Inc2.2M−56.8%$2158万0.5%
43ANRO Alto Neuroscience Inc785,000−62.0%$2072万0.5%
44TRAX First Tracks Biotherapeutics1.0M—$2038万0.5%
45LXEO Lexeo Therapeutics Inc4.3M−3.5%$2011万0.5%
46SVRA Savara Inc2.7M+4.6%$1676万0.4%
47DMRA Damora Therapeutics Inc575,000−4.2%$1496万0.3%
48SGP Spyglass Pharma Inc670,000+0.5%$1491万0.3%
49TECX Tectonic Therapeutic Inc425,000+29.6%$1461万0.3%
50AVTX Avalo Therapeutics Inc775,000—$1432万0.3%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。